Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Pain management in patients with multiple myeloma (2024) |
Auteurs : | Fatma Kammoun ; Katen Kallel ; Maha Charfi ; Moez Medhaffar ; Moez Elloumi |
Type de document : | Article |
Dans : | Douleurs (Vol. 25, n° 1, Février 2024) |
Article en page(s) : | p. 11-16 |
Note générale : | https://doi.org/10.1016/j.douler.2023.11.006 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Douleur ; Douleur nociceptive ; Maladies du système nerveux ; Myélome multiple ; Qualité de vie ; Syndromes neurotoxiques |
Résumé : |
Introduction : Multiple myeloma (MM) is an incurable hematological malignancy disabling by pain. This study aims to identify the frequency of pain in patients with this disease, its characteristics, and to report the modalities of its management.
Methods : Our study is retrospective about 115 newly diagnosed adult patients ( Results : Nociceptive pain and neuropathic pain were recorded in 76.5% and 20% of cases respectively. Treated by thalidomide, 30 patients (16%) developed chemotherapy-induced peripheral neuropathy. Psychological pain was not estimated in our study. The management of pain differs according to the mechanism and must involve specific treatment of MM. For our patients, a global response and control of the disease was noted in 69% of cases. Conclusion : Pain in myeloma is often complex and multifactorial. Adequate pain management requires supporting treatment and the control of the disease, which is a predictive adverse factor for pain control. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.em-premium.com/article/1644438 |